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ABSTRACT In the present study, it is shown that although Escherichia coli CFT073, a
human uropathogenic (UPEC) strain, grows in liquid glucose M9 minimal medium, it fails
to grow on glucose M9 minimal medium agar plates seeded with 106 CFU. The cells
on glucose plates appear to be in a “quiescent” state that can be prevented by various
combinations of lysine, methionine, and tyrosine. Moreover, the quiescent state is char-
acteristic of ~80% of E. coli phylogenetic group B2 multilocus sequence type 73 strains,
as well as 22.5% of randomly selected UPEC strains isolated from community-acquired
urinary tract infections in Denmark. In addition, E. coli CFT073 quiescence is not limited
to glucose but occurs on agar plates containing a number of other sugars and acetate
as sole carbon sources. It is also shown that a number of E. coli CFT073 mini-Tn5 meta-
bolic mutants (gnd, gdhA, pykF, sdhA, and zwf) are nonquiescent on glucose M9 minimal
agar plates and that quiescence requires a complete oxidative tricarboxylic acid (TCA)
cycle. In addition, evidence is presented that, although E. coli CFT073 quiescence and
persistence in the presence of ampicillin are alike in that both require a complete oxida-
tive TCA cycle and each can be prevented by amino acids, E. coli CFT073 quiescence oc-
curs in the presence or absence of a functional rpoS gene, whereas maximal persistence
requires a nonfunctional rpoS. Our results suggest that interventions targeting speciﬁc
central metabolic pathways may mitigate UPEC infections by interfering with quiescence
and persistence.
IMPORTANCE Recurrent urinary tract infections (UTIs) affect 10 to 40% of women.
In up to 77% of those cases, the recurrent infections are caused by the same uro-
pathogenic E. coli (UPEC) strain that caused the initial infection. Upon infection of
urothelial transitional cells in the bladder, UPEC appear to enter a nongrowing qui-
escent intracellular state that is thought to serve as a reservoir responsible for recur-
rent UTIs. Here, we report that many UPEC strains enter a quiescent state when
106 CFU are seeded on glucose M9 minimal medium agar plates and show that
mutations in several genes involved in central carbon metabolism prevent quies-
cence, as well as persistence, possibly identifying metabolic pathways involved in
UPEC quiescence and persistence in vivo.
KEYWORDS: E. coli quiescence, E. coli persistence, urinary tract infections, carbon
metabolism, TCA cycle
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Uncomplicated urinary tract infections (UTIs) affect about 25% of women in theirlifetime, and at least 80% of those infections are caused by uropathogenic Esch-
erichia coli (UPEC) (1). Recurrent UTIs affect between 10% and 40% of women (2), and
in up to 77% of those cases, the recurrent infections are caused by the same UPEC strain
that caused the initial infection (3, 4). UPEC infections generate annual costs in excess
of two billion dollars in the United States alone, placing a signiﬁcant burden on the
health care system (5). Although the causes of recurrent UTI are complex (6), it appears
that UPEC can bind to, enter, and replicate within superﬁcial facet cells in the human
and mouse bladder epithelium, resulting in intracellular bioﬁlmlike communities (IBCs)
(6, 7). IBCs escape from infected superﬁcial facet cells within hours of development (6).
The superﬁcial facet cells then exfoliate, exposing underlying transitional epithelial
cells, which can be infected with IBC-derived UPEC progeny (6, 8). Upon infection of
urothelial transitional cells, UPEC appear to enter a nongrowing quiescent intracellular
state (6, 8). These quiescent UPEC cells have been called quiescent intracellular reser-
voirs (QIRs) (6), and it is thought that QIRs are a major cause of recurrent UTIs (6, 8). QIRs
also help to explain why antibiotics have failed to eradicate UPEC reservoirs in the
bladders of mice, since quiescent UPEC may not be readily affected by antibiotics (6, 8).
The quiescence of QIRs and their insensitivity to antibiotics is reminiscent of the
persister state (8–11). Persister cells are dormant cells formed in normal microbial
populations as small subpopulations that are highly tolerant to antibiotics but upon
regrowth in the absence of antibiotics regain full sensitivity (11). Persisters appear to
play a major role in the ability of chronic infections to withstand antibiotic treatment
(11). In the present study, we report that when inocula of 106 CFU of E. coli CFT073,
the prototypic UPEC strain, as well as ~80% of phylogenetic group B2 multilocus
sequence type 73 (ST73) strains, of which E. coli CFT073 is a member, are plated on M9
minimal agar plates containing glucose as the sole carbon and energy source, they
appear to enter a “quiescent” state and that mutations in speciﬁc metabolic genes
appear to prevent that state. In addition, we show that E. coli CFT073 quiescence also
occurs in the presence of a number of other sugars and acetate as sole carbon sources
and that a complete tricarboxylic acid (TCA) cycle is required both for the generation
of E. coli CFT073 quiescent cells on glucose plates and for the formation of persister
cells generated in liquid glucose minimal medium in the presence of ampicillin.
RESULTS
E. coli CFT073, a UPEC strain, and E. coli Nissle 1917, a closely related probiotic
strain, grow in liquid glucose M9 minimal medium but fail to grow on glucose M9
minimal medium agar plates. We were attempting to determine which colicins and
microcins are active against the sequenced E. coli CFT073, a phylogenetic group B2
multilocus sequence type 73 (ST73) UPEC strain (20, 21), and the closely related ST73
probiotic strain, E. coli Nissle 1917 (22). As expected, we found that after overnight
incubation at 37°C, both strains formed lawns of growth on 0.2% glucose M9 minimal
medium agar plates (hereinafter called glucose plates) when either 107 or 108 CFU was
plated from an overnight 0.4% glucose M9 minimal medium liquid culture. Unexpect-
edly, however, when 106 CFU or fewer were plated on glucose plates, they failed to
form lawns or colonies after 24 h and 48 h of incubation at 37°C. This result was unusual
in that a number of human commensal E. coli strains, including MG1655, HS, F-18, EFC1,
and EFC2 (Table 1), and the O157:H7 strain E. coli EDL933 (Table 1) tested at 105 CFU
grew as lawns on the glucose plates after 24 h at 37°C, and viable counts could be
determined for each strain on glucose plates (not shown). That all the E. coli strains
tested for growth on glucose plates are spontaneous streptomycin-resistant mutants
(Table 1) but only E. coli CFT073 and E. coli Nissle 1917 failed to form lawns on glucose
plates seeded with106 CFU makes it highly unlikely that point mutations in ribosomal
proteins play a role in the observed lack of growth.
Picking colonies of E. coli MG1655 grown on glucose plates onto glucose plates
seeded with 105 or 106 CFU of E. coli CFT073 or E. coli Nissle 1917, using toothpicks,
resulted in E. coli CFT073 and E. coli Nissle 1917 growth around the picked colonies but
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not anywhere else on the plates after incubation for 24 h at 37°C (Fig. 1A) (using
toothpicks to transfer colonies in this manner is a normal procedure used in colicin and
microcin testing). No growth was observed around picked E. coli MG1655 colonies
grown on glucose plates that had not been seeded with E. coli CFT073 or E. coli Nissle
1917 (not shown). These results suggested that picked E. coli MG1655 was secreting a
molecule(s) (hereinafter called the MG1655 stimulus) as it grew on glucose plates that
was either preventing cell death of E. coli CFT073 and E. coli Nissle 1917 or preventing
them from entering a quiescent state. Incubating the plates that had been seeded with
105 CFU of E. coli CFT073 or E. coli Nissle 1917 for 48 h at 37°C resulted in much larger
regions of growth around the picked E. coli MG1655 colonies than at 24 h (Fig. 1B),
suggesting that cells could be stimulated to grow after 24 h of incubation and thereby
favoring the quiescence hypothesis and suggesting either that the MG1655 stimulus
was diffusible and active at a very low concentration or that growing E. coli CFT073 and
E. coli Nissle 1917 also secreted the stimulus. Also, when glucose plates seeded with 105
or 106 CFU of E. coli CFT073 or E. coli Nissle 1917 were incubated for 24 h at 37°C prior
to picking E. coliMG1655 to those plates, growth of E. coli CFT073 and E. coli Nissle 1917
was observed surrounding the picked E. coli MG1655 colonies after an additional 24-h
incubation at 37°C (not shown). Therefore, many of the E. coli CFT073 and E. coli Nissle
1917 cells were alive but quiescent on glucose plates for at least 24 h. Importantly,
quiescence is not observed when Difco Bacto agar is used in glucose plates instead of
Difco noble agar, suggesting that impurities in the former allow growth. It should be
noted that at this time, we do not know whether it is live or dead E. coli MG1655 cells
that are the source of the stimulus, as the picked cells grow on the glucose plates. Also,
it should be mentioned that E. coli CFT073 and E. coli Nissle 1917 quiescence is not
dependent on using 0.2% glucose M9 minimal medium agar plates, since identical
results were obtained using 0.4% glucose M9 minimal medium agar plates (not shown).
Testing additional E. coli strains for quiescence on glucose plates. E. coli
strains can be separated into four major phylogenetic groups (A, B1, B2, and D) and two
additional phylogenetic groups that have recently been deﬁned, phylogenetic group
AxB1, containing strains that derive most of their ancestry from A and B1, and
phylogenetic group ABD, containing a heterogeneous set of strains with multiple
sources of ancestry (23). Thirty E. coli strains representing various multilocus sequence
types (ST) of the 6 phylogenetic groups were grown in liquid glucose M9 minimal
medium, and the 30 strains were tested for the ability to grow on glucose plates seeded
TABLE 1 Bacterial strains
E. coli strain Genotype/phenotype Designation in text Source or reference
CFT073 Strr Spontaneous streptomycin-resistant mutant of CFT073, has 5-bp
duplication in rpoS
CFT073 53
CFT073 Strr mini-Tn5 Km::gdhA Mini-Tn5 Km glutamate dehydrogenase mutant of CFT073 Strr CFT073 gdhA This study
CFT073 Strr mini-Tn5 Km::gnd Mini-Tn5 Km 6-phosphogluconate dehydrogenase mutant of
CFT073 Strr
CFT073 gnd This study
CFT073 Strr mini-Tn5 Km::pykF Mini-Tn5 Km pyruvate kinase mutant of CFT073 Strr CFT073 pykF This study
CFT073 Strr mini-Tn5 Km::sdhA Mini-Tn5::Km ﬂavoprotein subunit of succinate dehydrogenase
mutant of CFT073 Strr
CFT073 sdhA This study
CFT073 Strr mini-Tn5 Km::zwf Mini-Tn5::Km glucose-6-phosphate dehydrogenase mutant of
CFT073 Strr
CFT073 zwf This study
Wild-type CFT073 Original clinical isolate CFT073 original clinical
isolate
34
Nissle 1917 Strr Spontaneous streptomycin-resistant mutant of Nissle 1917 Nissle 1917 57
MG1655 Strr Spontaneous streptomycin-resistant mutant of MG1655 MG1655 54
HS Strr Spontaneous streptomycin-resistant mutant of HS HS 55
EFC1 Strr Spontaneous streptomycin-resistant mutant of EFC1 EFC1 55
EFC2 Strr Spontaneous streptomycin-resistant mutant of EFC2 EFC2 55
F-18 Strr Nalr Spontaneous streptomycin- and nalidixic acid-resistant mutant of
F-18
F-18 56
EDL933 Strr Spontaneous streptomycin-resistant mutant of EDL933 EDL933 54
ATM161 Host for pUT, which contains the mini-Tn5 Km transposon
(kanamycin resistance)
ATM161 17
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with inocula of 105 CFU and to respond to the MG1655 stimulus. The strains used
included two ST10 and two ST453 strains from phylogenetic group A; two ST58, two
ST410, and two ST101 strains from phylogenetic group B1; two ST73, two ST95, and two
ST131 strains from phylogenetic group B2; two ST69, two ST354, and two ST648 strains
from phylogenetic group D; two ST90 and two ST642 strains from phylogenetic group
AxB1; and two ST62 and two ST117 strains from phylogenetic group ABD. Of the 30
strains, 2 failed to grow on glucose plates and those strains responded to the MG1655
FIG 1 E. coli CFT073 quiescence on glucose plates. A 0.2% glucose plate was seeded with 105 CFU of E. coli
CFT073 (see Materials and Methods). (A) Sixty minutes after seeding the plate, a colony of E. coli MG1655,
grown on a glucose plate, was transferred to the plate seeded with E. coli CFT073, using a toothpick; the plate
was then incubated at 37°C for 24 h. (B) The same plate, incubated for 48 h. Note that E. coli CFT073 only grows
around the picked E. coli MG1655. Although not shown, E. coli Nissle 1917 undergoes quiescence on glucose
plates identically.
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stimulus. The 2 strains that failed to grow on glucose plates were ST73 strains. ST73 is
a very common UPEC lineage, accounting for 11% and 16.6% of UPEC isolated from
patients in 2 recent studies (24, 25). Importantly, E. coli CFT073 and E. coli Nissle 1917
are also ST73 strains.
Testing additional ST73 strains for quiescence on glucose plates. Since it
appeared that quiescence on glucose agar plates might be characteristic of the ST73
lineage, 40 additional ST73 strains were tested for the ability to grow on glucose plates
seeded with inocula of 105 CFU and to respond to the MG1655 stimulus. Two of the
strains failed to grow overnight in liquid glucose M9 minimal medium, but of the 38
strains that grew, 30 (78.9%) failed to grow on glucose plates but responded to the
MG1655 stimulus. Therefore, the vast majority of ST73 strains, a major UPEC lineage (24,
25), are quiescent on glucose plates.
Testing 40 UPEC strains isolated from community-acquired UTIs in Den-
mark for quiescence on glucose plates. Forty randomly selected UPEC strains
isolated from community-acquired UTIs in Denmark were tested for the ability to grow
on glucose plates seeded with inocula of 105 CFU and to respond to the MG1655
stimulus. Of the 40 UPEC strains tested, all grew overnight in liquid glucose M9 minimal
medium, but 9 failed to grow on glucose plates (22.5%) unless stimulated to do so by
the MG1655 stimulus. Three of the 9 strains that failed to grow on glucose plates were
ST73 strains (5 of the 40 UPEC strains tested [12.5%] were ST73), and 3 were ST141
strains (3 of the 40 UPEC strains tested were ST141 strains [7.5%], a group not
represented in the original 30 strains tested). The 3 remaining strains that failed to grow
on glucose plates (ST104, ST394, and ST998) were not represented in the original 30
strains tested, and each was represented only once among the 40 UPEC strains tested
(2.5% each). It therefore appears that the inability to grow on glucose plates and yet
respond to the MG1655 stimulus is not limited to the ST73 group.
The inability of E. coli CFT073 to grow on minimal agar plates is not limited
to glucose as sole carbon source. E. coli CFT073 was tested for the ability of 105 CFU
to grow on M9 minimal medium agar plates containing 0.2% acetate, arabinose,
fructose, fucose, galactose, gluconate, glycerol, N-acetylglucosamine, maltose, man-
nose, ribose, and xylose as sole carbon sources. E. coli CFT073 grew overnight in liquid
M9 minimal medium containing each carbon source, but inocula of 105 CFU only grew
as lawns on agar plates containing glycerol, ribose, and xylose as sole carbon sources
(Fig. 2). On those plates where E. coli CFT073 failed to grow, it responded to the
MG1655 stimulus.
Human urine, a cocktail mimicking the amino acid composition of human
urine, and a cocktail mimicking amino acids present in a concentrated E. coli
MG1655 culture supernatant prevent E. coli CFT073 quiescence on glucose
plates. We normally pick a colony of E. coli MG1655 to a glucose plate as a source of
the MG1655 stimulus, suggesting that the stimulus is secreted on the plate as E. coli
MG1655 grows. However, no stimulus activity was found when 5 l or 20 l of a
cell-free supernatant derived from an overnight liquid glucose M9 minimal medium
culture of E. coli MG1655 was placed on a glucose agar plate seeded with 105 CFU of
E. coli CFT073 or E. coli Nissle 1917. Stimulus activity was observed when 5 l of a
cell-free supernatant derived from a 50-fold-concentrated E. coli MG1655 culture that
had been incubated overnight at 37°C (see Materials and Methods) was placed on a
glucose agar plate seeded with 105 CFU of E. coli CFT073 (Fig. 3A). Analysis of one such
E. coli MG1655 cell-free supernatant revealed the presence of a number of unknown
small molecules and 14 amino acids (Table 2). Importantly, 5 l of an amino acid
cocktail identical in composition to the amino acids in the 50-fold-concentrated E. coli
MG1655 supernatant displayed stimulus activity similar to that of 5 l of the 50-fold-
concentrated supernatant (Fig. 3B). A cell-free supernatant derived from a 50-fold-
concentrated E. coli CFT073 culture was nearly identical to the E. coli MG1655 super-
natant in amino acid composition but additionally contained aspartic acid (Table 2). As
expected, 5 l of the E. coli CFT073 cell-free supernatant also displayed stimulus
activity on glucose plates seeded with 105 CFU of E. coli CFT073. Perhaps even more
E. coli CFT073 Quiescence and Persistence In Vitro
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importantly, 5 l of sterile ﬁltered human urine collected from one of us and 5 l
of a cocktail mimicking the amino acid composition of human urine (Table 2) (26)
both displayed stimulus activity on glucose plates seeded with 105 CFU of E. coli
CFT073 (Fig. 3C and D).
Lysine, methionine, and tyrosine are involved in preventing quiescence.
One millimolar solutions of each of the 20 standard L-amino acids were prepared, and
5 l of each was tested on glucose plates seeded with 105 CFU of E. coli CFT073. None
displayed stimulus activity. However, when single amino acids were omitted from the
cocktails, testing 5 l of the cocktails mimicking the concentrations of amino acids in
FIG 2 E. coli CFT073 nonquiescence on glycerol, ribose, and xylose plates. Glucose, glycerol, ribose, and xylose plates (0.2% each) were seeded with
105 CFU of E. coli CFT073 grown overnight in liquid M9 minimal medium containing their respective sugars (0.4%). Sixty minutes after seeding the plates,
a colony of E. coli MG1655, grown on a glucose plate, was transferred to a glucose plate, using a toothpick. Plates were incubated at 37°C for 24 h. (A)
Glycerol; (B) ribose; (C) xylose; (D) glucose.
Leatham-Jensen et al.
Volume 1 Issue 1 e00055-15 msphere.asm.org 6
 o
n
 M
arch 13, 2017 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
urine (Table 2) and in the 50-fold-concentrated E. coli MG1655 supernatant (Table 2)
revealed that cocktails missing lysine, methionine, and tyrosine failed to stimulate.
Furthermore, although 5 l of 1.0 mM lysine alone, 1.0 mM methionine alone, and 1.0
mM tyrosine alone failed to stimulate (not shown), 5 l of mixtures of 1.0 mM each of
lysine, methionine, and tyrosine (Fig. 3E) were about as stimulatory for growth of E. coli
CFT073 on glucose plates as either the E. coli MG1655 amino acid cocktail (Fig. 3B) or
the amino acid cocktail mimicking human urine (Fig. 3D). Five microliters of mixtures of
FIG 3 Prevention of quiescence by human urine and amino acids. Glucose (0.2%) plates were seeded with 105 CFU of E. coli CFT073, and 5-l amounts
of the following mixtures were spotted onto the plates: (A) 50-fold-concentrated E. coli MG1655 culture supernatant; (B) amino acid cocktail mimicking
the amino acid concentrations in the 50-fold-concentrated E. coli MG1655 culture supernatant; (C) human urine; (D) amino acid cocktail mimicking the
amino acid concentrations in human urine (Table 3); (E) lysine, methionine, and tyrosine (1.0 mM each); (F) lysine and methionine (1.0 mM each); (G) lysine
and tyrosine (1.0 mM each); and (H) methionine and tyrosine (1.0 mM each). Plates were incubated at 37°C for 24 h. Although not shown, the results for
E. coli Nissle 1917 were essentially identical.
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1.0 mM each of D-lysine, D-methionine, and D-tyrosine failed to stimulate (not shown),
demonstrating the importance of the L- forms of the 3 amino acids in preventing
quiescence. Mixtures of 1.0 mM each of lysine and methionine (Fig. 3F) and 1.0 mM
each of lysine and tyrosine (Fig. 3G) also stimulated E. coli CFT073 growth on glucose
plates, although the stimulation of E. coli CFT073 growth by the mixture of lysine and
tyrosine was minimal (Fig. 3G). A mixture of 1.0 mM each of methionine and tyrosine
failed to stimulate E. coli CFT073 growth (Fig. 3H). In summary, E. coli MG1655 is not
required to provide the stimulus that prevents E. coli CFT073 quiescence; a mixture of
lysine, methionine, and tyrosine, found in 50-fold-concentrated E. coli MG1655 super-
natants, is just as effective.
E. coli CFT073 and E. coli Nissle 1917 but not E. coli MG1655 generate high
levels of persister cells in liquid glucose M9 minimal medium. Persister cells are
dormant cells formed in normal microbial populations as small subpopulations (103 to
104%) that are highly tolerant to antibiotics but, upon regrowth in the absence of
antibiotics, regain full sensitivity (11). Persister cells appear to play a role in the ability
of bacteria causing chronic infections to withstand antibiotic treatment (11). Because
E. coli CFT073 becomes quiescent on glucose plates and quiescence is reminiscent of
persistence, we wondered whether E. coli CFT073 would generate a high level of
persister cells in liquid glucose M9 minimal medium. Overnight cultures of E. coli
CFT073 grown on 0.4% glucose M9 minimal medium were diluted 20-fold into fresh
0.2% glucose M9 minimal medium (A600 of 0.1, ~108 CFU/ml) containing or lacking
ampicillin (100 g/ml), and viable counts were followed for 24 h at 37°C (Fig. 4). During
the ﬁrst 4 h of incubation, the viable counts in the E. coli CFT073 cultures decreased
10-fold in both the presence and absence of ampicillin, i.e., from 108 CFU/ml to
107 CFU/ml. No further cell death occurred between 4 h and 6 h in the absence of
ampicillin, and by 24 h, E. coli CFT073 had grown to almost 109 CFU/ml (Fig. 4). In
contrast, between 4 h and 6 h in the presence of ampicillin, the viable counts decreased
almost an additional 10-fold, to about 106 CFU/ml, in the E. coli CFT073 cultures (Fig. 4).
However, there was little further E. coli CFT073 death in the presence of ampicillin
between 6 h and 24 h (Fig. 4), suggesting the possibility that the survivors (~0.7%) at
24 h might be persisters. Therefore, at 24 h, E. coli CFT073 cultures containing ampicillin
were centrifuged, washed free of the antibiotic, resuspended in LB broth, and grown at
TABLE 2 Free-amino-acid composition of 50-fold-concentrated E. coli MG1655 and E. coli
CFT073 supernatants and human urine
Amino acid
Amt (M) of amino acid ina:
E. coli MG1655
supernatantb
E. coli CFT073
supernatantb
Human
urinec
Alanine 353 383 3,350
Arginine — — 205
Aspartic acid — 22 —
Cysteine — — 1,110
Glutamic acid 360 848 —
Glycine 11 86 21,200
Histidine — — 9,470
Isoleucine 90 170 478
Leucine 56 149 382
Lysine 7,472 4,059 4,480
Methionine 59 37 171
Phenylalanine 99 187 626
Proline 144 116 —
Serine 64 70 4,000
Threonine 201 461 2,430
Tryptophan 146 312 —
Tyrosine 13 52 1,060
Valine 229 748 349
a—, amino acid was not present in the preparation.
bSee Materials and Methods for details.
cAverage values of samples from 39 women (26).
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37°C for 2.25 h to 108 CFU/ml, at which time ampicillin was added (100 g/ml). Four
hours later, viable counts in the E. coli CFT073 LB broth cultures had dropped to
104 CFU/ml, suggesting that the vast majority of cells that survived ampicillin treatment
in liquid glucose M9 minimal medium were indeed persister cells, still fully sensitive to
ampicillin. Much like E. coli CFT073, E. coli Nissle 1917 generated a high level of persister
cells in liquid glucose minimal medium, i.e., about 2.6% at 24 h (Table 3), and the cells
were still sensitive to ampicillin, as described above.
Unlike E. coli CFT073 and E. coli Nissle 1917, when E. coli MG1655 overnight cultures
were diluted 20-fold into fresh 0.2% glucose M9 minimal medium, viable counts
increased immediately in the absence of ampicillin, and in the presence of ampicillin,
decreased continuously for 6 h to a level of about 103 CFU/ml (103%) and remained
at that level at 24 h (Fig. 4). The E. coli MG1655 survivors in cultures containing
ampicillin were also persister cells, i.e., when regrown in LB broth without ampicillin,
they regained sensitivity. Therefore, when grown in liquid glucose M9 minimal medium,
E. coli CFT073 and E. coli Nissle 1917 cultures generated about 1,000-fold more persister
cells than E. coli MG1655 cultures.
E. coli CFT073 generates a low level of persister cells in liquid glucose M9
minimal medium containing amino acids. Since amino acids reversed E. coli
CFT073 quiescence on glucose plates, we were interested in determining whether the
addition of a mixture of the 20 standard L-amino acids (100 g/ml each) to cultures of
E. coli CFT073 grown in glucose M9 minimal medium in the absence of amino acids
FIG 4 E. coli CFT073 and E. coli MG1655 persistence. Cultures were grown overnight in 0.4% glucose
M9 minimal medium as described in Materials and Methods. Persister cell assays were performed as
described in Materials and Methods. Œ, E. coli CFT073; , E. coli CFT073 plus ampicillin; , E. coli
MG1655; , E. coli MG1655 plus ampicillin. Bars representing standard errors of the means of counts
from 2 independent experiments are presented for each time point. At 24 h, the approximately
1,000-fold difference between the counts of E. coli CFT073 persisters and E. coli MG1655 persisters in
the presence of ampicillin is statistically significant (P  0.0052).
TABLE 3 E. coli CFT073 persister cells relative to persister cells for other E. coli strains
E. coli strain
No. of
experiments
% of persister
cells  SEMa
Persister cell
ratio of CFT073
and indicated straina P valueb
CFT073 7 0.71  0.19 
CFT073 gnd 2 0.34  0.18 1.65 0.44
CFT073 pykF 2 2.37  0.18 0.23 0.075
CFT073 zwf 2 0.29  0.29 1.45 0.43
Nissle 1917 2 2.64  1.22 0.21 0.16
True wild-type CFT073 2 (2.80  1.1)  104 1,160 0.025
aThe percentage of persister cells was calculated by dividing the viable count at 24 h by the viable count at
time zero times 100. The value for E. coli CFT073 persister cells relative to a speciﬁc E. coli strain was
calculated by dividing the percentage of persister cells generated by E. coli CFT073 at 24 h in the
experiments for each speciﬁc strain by the percentage of persister cells generated by that speciﬁc strain at
24 h in those experiments.
bA P value of 0.05 using the two-tailed Student’s t test is considered to be statistically signiﬁcant.
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would generate fewer persister cells. As shown by the results in Fig. 5, in the presence
of the amino acid mixture and absence of ampicillin, E. coli CFT073 viable counts
increased immediately, reaching stationary phase within 4 h. Importantly, in the
presence of both the amino acid mixture and ampicillin, E. coli CFT073 viable counts
decreased continuously for 24 h, to a level of about 5  103 CFU/ml (Fig. 5). That the
survivors at 24 h were persister cells was shown by the fact that when regrown in LB
broth without ampicillin, they regained sensitivity, as described above. In the absence
of amino acids and presence of ampicillin, E. coli CFT073 persister cells were again
generated, at a level of about 106 CFU/ml (Fig. 5). Therefore, in the presence of amino
acids, about 100-fold fewer E. coli CFT073 persister cells were generated than in their
absence (Fig. 5).
Isolation and characterization of E. coli CFT073 mini-Tn5 mutants that
grow on glucose plates. Since E. coli CFT073 grows overnight in liquid glucose M9
minimal medium but not on glucose plates, we thought it possible that the expression
of one or more genes on glucose plates but not in liquid glucose cultures might be
responsible. If so, knockout of the responsible gene(s) would result in growth on
glucose plates. Therefore, E. coli CFT073 mini-Tn5 Km (kanamycin) mutants were
generated by random insertional mutagenesis (see Materials and Methods), and any
mutant that grew as lawns on glucose plates was conﬁrmed by transferring the
insertion into a fresh E. coli CFT073 background and retesting it for growth on glucose
plates (see Materials and Methods).
Five conﬁrmed nonquiescent mini-Tn5 Km mutants were isolated from approxi-
mately 2,000 mutants tested. E. coli CFT073 and the mini-Tn5 Km mutants were grown
overnight in liquid glucose M9 minimal medium, and viable counts were made on both
glucose plates and LB agar plates. As expected, E. coli CFT073 assayed from the
overnight cultures failed to grow on the glucose plates when inocula of106 CFU were
plated, but when assayed on LB agar, viable counts showed that the cultures contained
~109 CFU/ml. In contrast, when assayed on either glucose plates or LB agar plates, the
5 mini-Tn5 Kmmutant cultures each contained about ~109 CFU/ml. It therefore appears
that the mini-Tn5 Km insertion in each of the 5 genes completely prevented quiescence
on glucose plates.
The mini-Tn5 Km insertions that resulted in mutants able to grow on glucose plates
after transfer into a fresh E. coli CFT073 background were in the sdhA, gnd, zwf, pykF,
and gdhA genes (Fig. 6). (i) sdhA encodes the succinate-binding ﬂavoprotein subunit of
succinate dehydrogenase (27). As a consequence of the mutation, the E. coli CFT073
FIG 5 E. coli CFT073 persistence in the presence of amino acids. Cultures were grown in 0.4%
glucose M9 minimal medium as described in Materials and Methods and diluted 20-fold into 0.2%
glucose M9 minimal medium either containing or lacking a mixture of the 20 standard L-amino acids,
each at 100 g/ml, and containing or lacking ampicillin (100 g/ml). , E. coli CFT073; , E. coli
CFT073 plus ampicillin; Œ, E. coli CFT073 plus amino acids; , E. coli CFT073 plus amino acids plus
ampicillin. Bars representing standard errors of the means of counts from 2 independent experiments
are presented for each time point. At 6 h and 24 h, the approximately 100-fold differences between
E. coli CFT073 persisters and E. coli MG1655 persisters in the presence of ampicillin are statistically
significant (P  0.002 and P  0.05, respectively).
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sdhA mutant fails to grow on succinate as a sole carbon source, but it grows normally
on glucose. (ii) gnd encodes 6-phosphogluconate dehydrogenase, which functions in
the oxidative branch of the pentose phosphate pathway to synthesize ribulose-5-
phosphate from 6-phosphogluconate (28, 29). Ribulose-5-phosphate is an essential
precursor in the synthesis of FAD, nucleotides, and lipopolysaccharides (LPS). (iii) zwf
encodes glucose-6-phosphate dehydrogenase, which functions in the oxidative branch
of the pentose phosphate pathway and the Entner-Doudoroff pathway when E. coli is
grown on glucose (28, 29). (iv) pykF encodes pyruvate kinase, which converts phos-
phoenolpyruvate to pyruvate in the Embden-Meyerhof-Parnas pathway (30). (v) gdhA
encodes glutamate dehydrogenase, which catalyzes the amination of -ketoglutarate
to glutamate (31).
FIG 6 Diagram of E. coli central carbon metabolism. Arrows indicate the physiological directions of the
reactions. Genes encoding the enzymes for each reaction are listed beside each reaction. Mini-Tn5 Km
insertions in E. coli CFT073 genes that result in nonquiescence on glucose plates are circled. P, phosphate;
KDPG, 2-keto-3-deoxy-6-phosphogluconate.
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It might be argued that the mini-Tn5 Km insertions in the identiﬁed genes are not
the cause of nonquiescence but, rather, that nonquiescence is caused by downstream
polarity effects. Indeed, the mini-Tn5 Km transposon used in the present study has
strong transcription termination sequences ﬂanking both ends of the kanamycin
resistance gene (17). However, the intergenic number of nucleotides and nucleotide
sequences between gnd and the immediately downstream gene ugd, between pykF
and the immediately downstream gene lpp, and between zwf and the immediately
downstream gene edd are identical in E. coli MG1655 and E. coli CFT073 (GenBank
accession numbers U00096.3 and AE014075.1) (21, 32). Moreover, in E. coliMG1655 and,
therefore, in E. coli CFT073, there is a strong presumptive promoter between gnd and
ugd (33), and in E. coli MG1655 and, therefore, in E. coli CFT073, both lpp and edd have
their own experimentally identiﬁed promoters (33). It is therefore highly likely that
nonquiescence is caused by interrupting gnd, pykF, and zwf and not by downstream
polarity effects. Also, in E. coli CFT073, gdhA is immediately upstream from c2163, which
is transcribed in the opposite direction to gdhA (21), making it highly unlikely that
nonquiescence caused by the insertion in gdhA is due to downstream polarity. Finally,
although in E. coliMG1655, the number of nucleotides between the end of the sdhCDAB
operon and the beginning of the immediately downstream sucABCD operon is 241
nucleotides less than that in E. coli CFT073 (GenBank accession numbers U00096.3 and
AE014075.1) (31, 32), the experimentally identiﬁed E. coli MG1655 sucABCD promoter is
identical in sequence to the presumptive E. coli CFT073 sucABCD promoter, and the
nucleotide sequence between the 3= end of the promoter and the start of sucA
transcription is identical in both strains (21, 32, 33). It is therefore highly unlikely that
nonquiescence caused by the insertion in sdhA is due to a downstream polarity effect
on the sucABCD operon in E. coli CFT073.
Of the 5 mini-Tn5 Km mutants, only E. coli CFT073 sdhA and gdhA mutants
generate low levels of persister cells. Since the 5 E. coli CFT073 mini-Tn5 Km
mutants were nonquiescent on glucose plates, we wondered whether they would
generate fewer persister cells than E. coli CFT073 in glucose M9 minimal medium.
Indeed, the E. coli CFT073 sdhA and gdhA mutants, which began growth shortly after
dilution of overnight cultures into fresh glucose M9 minimal medium, generated only
about 5  102 persister cells/ml, i.e., about 2,000-fold fewer persister cells in the
presence of ampicillin than wild-type E. coli CFT073 (Fig. 7 and Fig. 8). In contrast, the
E. coli CFT073 gnd, pykF, and zwf mutants generated about the same levels of persister
cells as E. coli CFT073 (Table 3), suggesting that quiescence and persistence are not
identical phenomena.
FIG 7 E. coli CFT073 sdhA persistence. Cultures were grown overnight in 0.4% glucose M9 minimal
medium, and persister cell assays were performed as described in Materials and Methods., E. coli
CFT073;, E. coli CFT073 plus ampicillin;Œ, E. coli CFT073 sdhA;, E. coli CFT073 sdhA plus ampicillin.
Bars representing standard errors of the means of counts from 4 independent experiments are
presented for each time point. At 24 h, the approximately 2,000-fold difference between E. coli
CFT073 persisters and E. coli CFT073 sdhA persisters in the presence of ampicillin is statistically
significant (P < 0.001).
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E. coli CFT073 persistence and quiescence require a complete TCA cycle.
Succinate dehydrogenase converts succinate to fumarate (Fig. 6). The fact that the
E. coli CFT073 sdhA mutant generated about 2,000-fold fewer persister cells than E. coli
CFT073 suggested the possibility that the ability to make fumarate from succinate was
required for persister cell formation. To test that possibility, E. coli CFT073 sdhA cultures
were grown overnight in liquid 0.4% glucose M9 minimal medium in the presence and
absence of fumarate (200 g/ml), and persister cell assays were performed in 0.2%
glucose M9 minimal medium in the presence of fumarate for cultures grown with
fumarate and in the absence of fumarate for cultures grown without fumarate. In the
presence of fumarate and ampicillin, E. coli CFT073 sdhA cultures generated between
105 and 106 CFU/ml persister cells (Fig. 9), much like E. coli CFT073 (Fig. 4, 5, 7, and 8),
whereas in the absence of fumarate and the presence of ampicillin, E. coli CFT073 sdhA
cultures generated only 5  102 CFU/ml persister cells (Fig. 9). Therefore, allowing
completion of the TCA cycle by supplying E. coli CFT073 sdhA with fumarate rescued its
ability to generate a high level of persister cells, suggesting that a complete oxidative
TCA cycle is required for maximal persister cell generation.
FIG 8 E. coli CFT073 gdhA persistence. Cultures were grown overnight in 0.4% glucose M9 minimal
medium, and persister cell assays were performed as described in Materials and Methods., E. coli
CFT073; , E. coli CFT073 plus ampicillin; Œ, E. coli CFT073 gdhA; , E. coli CFT073 gdhA plus
ampicillin. Bars representing standard errors of the means of counts from 3 independent experiments
are presented for each time point. At 24 h, the approximately 2,000-fold difference between E. coli
CFT073 persisters and E. coli CFT073 gdhA persisters in the presence of ampicillin is statistically
significant (P < 0.001).
FIG 9 E. coli CFT073 sdhA persistence in the presence of fumarate. Cultures were grown overnight
in 0.4% glucose M9 minimal medium containing or lacking disodium fumarate (200 g/ml) and then
diluted 20-fold into 0.2% glucose M9 minimal medium containing or lacking fumarate, and persister
cell assays were performed as described in Materials and Methods. Œ, E. coli CFT073 sdhA; , E. coli
CFT073 sdhA plus ampicillin; , E. coli CFT073 sdhA plus fumarate; , E. coli CFT073 sdhA plus
fumarate plus ampicillin. Bars representing standard errors of the means of counts from 2 indepen-
dent experiments are presented for each time point. At 6 h and 24 h, the differences between E. coli
CFT073 sdhA persisters in the presence and absence of fumarate are statistically significant (P 
0.013 and P  0.046, respectively).
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Since persister cell generation required a complete TCA cycle, we wondered
whether the same was true of quiescence. To that end, E. coli CFT073 sdhA was grown
overnight in liquid 0.4% glucose M9 minimal medium in the presence and absence of
fumarate (200 g/ml). Glucose plates containing fumarate (200 g/ml) were seeded
with 105 CFU of E. coli CFT073 sdhA grown in the presence of fumarate or 105 CFU of
E. coli CFT073 sdhA grown in the absence of fumarate and were incubated at 37°C for
24 h. In both cases, E. coli CFT073 sdhA failed to grow but responded to 5 l of a 1.0
mM mixture of lysine, methionine, and tyrosine (Fig. 10A), suggesting not only that the
presence of fumarate in the glucose plate rescued quiescence but that quiescence was
generated on the glucose plate and not in the liquid culture. As a control, glucose
plates without fumarate were seeded with 105 CFU of E. coli CFT073 sdhA grown
overnight in liquid glucose M9 minimal medium in the absence of fumarate and plates
were incubated at 37°C for 24 h. As expected, a lawn of E. coli CFT073 sdhA growth was
observed on the glucose plates under these conditions (Fig. 10B). Therefore, not only
does fumarate rescue the ability of E. coli CFT073 sdhA to generate a high level of
persisters in liquid glucose M9 minimal medium in the presence of ampicillin (Fig. 9),
it rescues the ability of E. coli CFT073 sdhA to enter the quiescent state on glucose
plates. As a side note, rescue by fumarate, obviating the need for succinate dehydro-
genase, further implicates the mini-Tn5 Km insertion and not a downstream polarity
effect as the cause of nonquiescence and reduced persistence of the sdhA mutant.
The E. coli CFT073 original clinical isolate is quiescent on glucose plates
but generates very few persister cells in liquid glucose M9 minimal medium.
As we were completing this study, we became aware of a paper reporting that the
sequenced E. coli CFT073 (22), which has long been considered to be the wild-type
strain, has a 5-bp duplication in rpoS which results in a truncated, nonfunctional RpoS
(34). RpoS, often referred to as the alternative sigma factor S, directs RNA polymerase
to transcribe genes involved in the E. coli general stress response, e.g., acid resistance
(35). The E. coli CFT073 strain used in this study does indeed have the 5-bp duplication
in rpoS (M. P. Leatham-Jensen, unpublished results). We therefore obtained and tested
the original clinical isolate of E. coli CFT073, which has a wild-type rpoS gene (34), for
quiescence and persister cell formation. The E. coli CFT073 original clinical isolate is
indeed quiescent on glucose plates and responds to lysine, methionine, and tyrosine
like the rpoS mutant used here (Fig. 11), but it generates about 2,000-fold fewer
persister cells in liquid glucose M9 minimal medium than the rpoS mutant used in the
present study (Table 3). Therefore, it appears that the mutant rpoS gene is necessary for
the high level of persistence observed but not for E. coli CFT073 quiescence on glucose
plates.
DISCUSSION
The data presented here show that the uropathogen E. coli CFT073 and the probiotic
E. coli Nissle 1917, both ST73 strains belonging to phylogenetic group B2, are quiescent
on glucose plates seeded with 106 CFU, as are 35/45 (77.8%) additional ST73 strains
tested. ST73 is a very common UPEC lineage (24, 25). In contrast, of 4 phylogenetic
group A, 6 phylogenetic group B1, 6 phylogentic group D, 4 phylogenetic group ABD,
and 4 phylogenetic group AxB1 strains, none (0/24) were quiescent. However, 9 of 40
randomly selected UPEC strains isolated from community-acquired UTIs in Denmark
(22.5%) were quiescent on glucose plates (3/5 ST73 strains, 3/3 ST141 strains, 1/1 ST104
strain, 1/1 ST394 strain, and 1/1 ST998 strain). Thus, quiescence on glucose plates is
common among UPEC isolates and is not restricted to one ST type.
The data presented here also show that the E. coli CFT073 original clinical isolate, like
the E. coli CFT073 strain used here, which has a 5-bp duplication in rpoS that inactivates
the gene (33), is quiescent on glucose plates (Fig. 11), but unlike the E. coli CFT073 strain
used here, the E. coli CFT073 original clinical isolate generates a low level of persister
cells in the presence of ampicillin (Table 3). Therefore, quiescence and persistence,
while similar in some respects, i.e., both are prevented by amino acids and both require
a complete oxidative TCA cycle, are not identical. In addition, quiescence and persis-
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tence differ in that of the 5 E. coli CFT073 mini-Tn5 nonquiescent mutants isolated in
the present study (gdhA, gnd, pykF, sdhA, and zwf mutants), only 2 (gdhA and sdhA)
were deﬁcient in persister cell formation (Table 3).
It has been reported previously, as reported here for E. coli CFT073, that deleting
rpoS in E. coli K-12 also dramatically increases the formation of persister cells in the
presence of ampicillin (36). Why then, does E. coli Nissle 1917, which has a wild-type
FIG 10 Rescue of E. coli CFT073 sdhA quiescence by fumarate. E. coli CFT073 sdhAwas grown overnight in 0.4%
glucose M9 minimal medium, and inocula of 105 CFU were seeded on 0.2% glucose plates containing disodium
fumarate (200 g/ml) (A) or 0.2% glucose plates (B). One hour later, 5 l of a mixture of 1.0 mM lysine, 1.0 mM
methionine, and 1.0 mM tyrosine was spotted to each plate, and the plates were incubated at 37°C for 24 h.
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rpoS gene (36; M. P. Leatham-Jensen, unpublished results), generate at least as high a
level of persister cells as E. coli CFT073 (Table 3)? E. coli Nissle 1917 would be expected
to be acid resistant, since a wild-type rpoS gene is required for acid resistance; however,
it has been reported to be extremely acid sensitive (37). This suggests the possibility
that the E. coli Nissle 1917 rpoS gene may be poorly expressed or that RpoS is rapidly
degraded, which is consistent with its generating as high a level of persister cells as the
E. coli CFT073 rpoS mutant used here. Many E. coli strains contain wild-type rpoS genes
that are expressed poorly relative to the rpoS expression in other strains (38).
While it is unclear why E. coli CFT073 gnd and zwf mutants are nonquiescent on
FIG 11 Quiescence of the E. coli CFT073 original clinical isolate on glucose plates. Glucose (0.2%) plates were seeded with 105 CFU of the E. coli CFT073
original clinical isolate, and 5-l amounts of the following mixtures (containing 1.0 mM of each amino acid) were spotted onto the plates: (A) lysine,
methionine, and tyrosine; (B) lysine and methionine; (C) lysine and tyrosine; (D) methionine and tyrosine. The plates were incubated at 37°C for 24 h.
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glucose plates, the reason why E. coli K-12 gnd and zwf mutants grow on glucose as
the sole carbon source is known (29, 30). When E. coli K-12 is grown on glucose as the
sole carbon source, glucose-6-phosphate dehydrogenase, encoded by zwf, and
6-phosphogluconate dehydrogenase, encoded by gnd, are used for the synthesis of
ribulose-5-phosphate via the oxidative branch of the pentose phosphate pathway
(Fig. 6) (28, 29). Ribulose-5-phosphate is an essential precursor in the synthesis of
FAD, nucleotides, and LPS. Furthermore, both enzymes generate NADPH for bio-
synthesis. It might therefore seem surprising that mutations in gnd and zwf allow
growth on glucose as the sole carbon source (Fig. 6). However, null mutations in
gnd and zwf in E. coli K-12 do not signiﬁcantly affect the growth of the mutants on
glucose because the nonoxidative branch of the pentose phosphate pathway runs
backwards in these mutants, generating ribulose-5-phosphate from fructose-6-
phosphate and glyceraldehyde-3-phosphate (Fig. 6) (28, 29) and the necessary NADPH
for biosynthesis by increased ﬂux through the TCA cycle (28, 29). It is therefore possible
that, for unknown mechanistic reasons, the oxidative branch of the pentose phosphate
pathway operates minimally during quiescence for E. coli CFT073, generating little
ribulose-5-phosphate, but that the gnd and zwf mutations cause the nonoxidative
branch to run backwards and ﬂux through the TCA cycle to increase, generating
sufﬁcient levels of ribulose-5-phosphate and NADPH to prevent quiescence. This sce-
nario is consistent with the observation that ribose and xylose, both of which are
metabolized in the nonoxidative branch of the pentose phosphate pathway, prevent
quiescence when used as sole carbon sources (Fig. 2).
The E. coli CFT073 pykFmutant also grows on glucose as the sole carbon source. The
pykF gene encodes pyruvate kinase, which converts phosphoenolpyruvate (PEP) to
pyruvate (Fig. 6). There is a second pyruvate kinase, encoded by pykA, but during the
growth of E. coli K-12 in glucose minimal medium, it contributes little to total pyruvate
kinase activity (39). Moreover, in the complete absence of pyruvate kinase, pyruvate can
still be generated in E. coli K-12 both through glucose transport via the phosphotrans-
ferase transport system (PTS) (40) and via the Entner-Doudoroff pathway (31, 38).
Therefore, it is not surprising that the nonquiescent E. coli CFT073 pykF mutant can
grow on glucose as sole carbon source, but why is it nonquiescent? It has been
suggested that pykF mutants contain increased intracellular levels of PEP (30). If PEP, a
common precursor in lysine, methionine, and tyrosine biosynthesis (Fig. 6), is increased
in the E. coli CFT073 pykF mutant growing on glucose plates, sufﬁcient intracellular
levels of the 3 amino acids might be generated to stimulate growth and prevent
quiescence.
The gdhA gene encodes glutamate dehydrogenase, which converts -ketoglutarate
to glutamate (Fig. 6). It is known that E. coli K-12 gdhA mutants grow on glucose as the
sole carbon source in the absence of glutamate dehydrogenase because glutamate can
also be synthesized via the sequential action of glutamine synthetase and glutamate
synthase (31, 41). Therefore, it appears that the switch from producing glutamate via
glutamate dehydrogenase to producing it via glutamine synthetase and glutamate
synthase in E. coli CFT073 somehow prevents quiescence. It has been estimated that
88% of assimilated nitrogen in E. coli, including the nitrogen in amino acids, originates
from glutamate, and the remaining 12% from glutamine (42). Perhaps glutamate and
glutamine are in higher concentrations in gdhA mutants growing on glucose, which
could contribute to higher intracellular levels of lysine, methionine, and tyrosine and,
as a consequence, nonquiescence.
E. coli K-12 succinate dehydrogenase mutants grow on glucose as a sole carbon
source because it is not necessary for the TCA cycle to function as a complete oxidative
cycle to achieve growth (43). In fact, when growing on excess glucose, the E. coli K-12
TCA cycle operates in branched mode, i.e., an oxidative branch which runs from citrate
to -ketoglutarate and a reductive branch which runs backwards from oxaloacetate to
succinyl-coenzyme A (CoA) (Fig. 6) (43). Succinate dehydrogenase is not necessary
under these conditions, and both branches serve biosynthetic functions. As a result,
neither branch is used for ATP generation (43). ATP is generated from glycolysis and via
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the phosphotransacetylase (pta)-acetate kinase (ackA) pathway, producing acetate in
the process (Fig. 6) (43). Therefore, it appears likely that forcing the TCA cycle to operate
in branched mode somehow prevents E. coli CFT073 quiescence. In branched mode,
the TCA cycle is unable to regenerate oxaloacetate and therefore gets oxaloacetate
from PEP via PEP carboxylase (Ppc) (Fig. 6). Perhaps under these conditions, sufﬁcient
oxaloacetate is generated via Ppc to increase the intracellular levels of lysine and
methionine (Fig. 6) and, consequently, prevent quiescence. In this vein, the addition of
fumarate to glucose plates results in the return of the E. coli CFT073 sdhA mutant to
quiescence, presumably by rescuing the ability of the TCA cycle to operate as a
complete oxidative cycle. It should also be noted that an E. coli CFT073 succinate
dehydrogenase mutant (sdhB) has been shown to be severely attenuated in an ascend-
ing UTI mouse model (44), indicating a possible link between in vitro nonquiescence
and reduced pathogenesis in vivo.
While it is clear why the E. coli CFT073 mini-Tn5 Km nonquiescent mutants are
capable of growth using glucose as the sole carbon source, it is not mechanistically
clear why the mutations prevent quiescence on glucose plates. Possibly a gene
encoding a regulator whose synthesis or activity is inhibited by various combinations
of lysine, methionine, and tyrosine promotes quiescence. The regulator would presum-
ably be expressed or active in the vast majority of E. coli CFT073 cells on glucose plates
but in relatively few cells of the E. coli CFT073 mini-Tn5 Km nonquiescent mutants due
to the complex metabolic changes that occur in such mutants (28–30, 39, 45, 46). If the
expression and activity of a speciﬁc E. coli CFT073 regulator is critical for the generation
of quiescence, much as toxin/antitoxin systems appear to be critical in generating
persister cells (11, 47), screening more mini-Tn5 Km mutants may lead to its identiﬁ-
cation. Furthermore, it is unclear why the E. coli CFT073 gdhA and sdhA mutants
generate far fewer persister cells than the gnd, zwf, and pykF mutants (Table 3).
Metabolic ﬂux analysis (28–30) and RNA-seq (48) may prove useful in this regard.
How might the ﬁndings reported here be relevant to recurrent UTI infections,
and how might their relevance be tested? It is known that E. coli CFT073 utilizes
amino acids and small peptides as carbon sources and a complete oxidative TCA
cycle to infect the mouse urinary tract (44, 49), and it appears to import small
peptides to grow in mouse urine in vitro (44). UPEC may also use peptides for
growth in vivo in urine during human UTI (50). It is also known that E. coli CFT073
can infect mouse superﬁcial facet cells and form intracellular bioﬁlmlike commu-
nities (IBCs) (51) and, therefore, most likely can form quiescent intracellular reser-
voirs (QIRs) in underlying transitional cells. Furthermore, it seems reasonable that
QIRs surviving antibiotic treatment serve as a reservoir for recurrent UTI infection
after the withdrawal of antibiotics (8, 10), i.e., as transitional cells undergo apoptosis
and released QIRs resume growth in urine, using peptides and amino acids in the
process (44, 49, 50). However, it should be noted that the role of QIRs in recurrent
UTI is still controversial. It has recently been shown that UPEC strains isolated from
the feces and urine of female patients during recurrent episodes are identical,
consistent with the possibility that recurrent UTI is caused by UPEC strains that
colonize the intestine but periodically move to the urinary tract (52). Nevertheless,
if the in vitro quiescence reported here mimics the QIR state and if QIRs are a major
source of recurrent UTI, the E. coli CFT073 nonquiescent mutants we have isolated
should be less able to establish QIRs in the mouse bladder and, therefore, be less
able to cause recurrent UTI. If so, it is possible that drugs designed to inactivate the
enzymes encoded by gdhA, gnd, pykF, sdhA, and zwf might be effective in limiting
recurrent urinary tract infection. On the other hand, if the in vitro persistence state
mimics the QIR state in mouse bladder cells, only the E. coli CFT073 gdhA and sdhA
mutants should be less able to cause recurrent UTI, and if so, drugs designed to
inactivate the enzymes encoded by gdhA and sdhA might be effective in limiting
recurrent urinary tract infection A recurrent UTI mouse model is available for testing
these hypotheses (8).
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MATERIALS AND METHODS
Bacterial strains. The E. coli CFT073, MG1655, and Nissle 1917 strains used in this study are listed in
Table 1. The original E. coli K-12 strain was obtained from a stool sample from a convalescing diphtheria
patient in Palo Alto, CA, in 1922 (12). The sequenced E. coli MG1655 strain (CGSC 7740) was derived from
the original K-12 strain, having only been cured of the temperate bacteriophage lambda and the F
plasmid by means of UV light and acridine orange treatment (12). E. coli Nissle 1917 was originally
isolated during World War I from a soldier who escaped a severe outbreak of diarrhea (13). It has a
beneﬁcial effect on several types of intestinal disorders, is well tolerated by humans, and has been
marketed as a probiotic remedy against intestinal disorders in several European countries since the 1920s
(13). E. coli strains tested for quiescence as described in “Testing additional E. coli strains for quiescence
on glucose plates” and “Testing additional ST73 strains for quiescence on glucose plates” in Results are
from the E. V. Sokurenko collection, and the E. coli strains used as described in “Testing 40 UPEC strains
isolated from community-acquired UTIs in Denmark for quiescence on glucose plates” in Results are from
the N. Frimodt-Møller and K. L. Nielsen collection.
Media. LB broth (Lennox) (Difco Laboratories) and LB agar (Lennox) (Difco Laboratories) were used
for routine cultivation. SOC medium was prepared as described by Datsenko and Wanner (14). Liquid M9
minimal medium (15) and M9 minimal medium agar plates were supplemented with reagent grade
(Sigma-Aldrich, Inc.) L-arabinose (0.2%, wt/vol), N-acetyl-D-glucosamine (0.2%, wt/vol), L-fucose (0.2%,
wt/vol), D-fructose (0.2%, wt/vol), D-glucose (0.2%, wt/vol), D-galactose (0.2%, wt/vol), D-gluconate (0.2%,
wt/vol), glycerol (0.2%, vol/vol), D-mannose (0.2%, wt/vol), maltose (0.2%, wt/vol), D-ribose (0.2%, wt/vol),
D-xylose (0.2%, wt/vol), potassium acetate (0.4%, wt/vol), sodium succinate (0.4%, wt/vol), and various
amino acids, as indicated in Results. Since Difco Bacto agar contains impurities, M9 minimal medium agar
plates were made with 1.6% Difco noble agar (Difco).
Lawn assay for quiescence. All E. coli strains were streaked from stored (80°C) LB broth-grown
cultures diluted 1:1 with 50% (vol/vol) glycerol to LB agar plates, which were incubated overnight at 37°C.
A loopful of cells from each streak plate was then grown overnight in 10 ml of 0.4% glucose M9 minimal
medium at 37°C with shaking in 125-ml tissue culture bottles. Routinely, 105 CFU from an overnight
culture was added to a tube containing 3 ml of liquid overlay medium (0.2% glucose M9 minimal
medium, 0.7% Difco noble agar at 45°C). Each tube containing inoculated overlay medium was imme-
diately poured onto a prewarmed (37°C) 0.2% glucose M9 minimal medium agar plate. Inoculated
overlays were allowed to solidify (with lids slightly ajar) for 1 h at room temperature. In addition, as
indicated, solidiﬁed inoculated overlays were stabbed with colonies of E. coli MG1655 grown on 0.4%
glucose M9 minimal medium agar plates, using sterile toothpicks, or were spotted with 5 l to 20 l of
ﬁltered E. coli MG1655 culture supernatant, human urine, or deﬁned amino acid solutions. Spots were
allowed to dry prior to incubation of plates. Plates were incubated for 24 h or 48 h at 37°C, as indicated.
Strains that grew as lawns on 0.2% glucose M9 minimal medium agar plates were considered to be
nonquiescent, and strains that grew in liquid 0.2% glucose M9 minimal medium, failed to grow on 0.2%
glucose M9 minimal medium agar plates, but were stimulated to grow around E. coli MG1655 stabs were
considered to be quiescent (see Results).
Insertional mutagenesis. Mini-Tn5 kanamycin (Km) mutants were constructed by insertional mu-
tagenesis as described previously (16). Brieﬂy, the donor strain E. coli ATM161 (17), carrying the suicide
vector pUT, which contains the mini-Tn5 Km transposon, was conjugated with the recipient strain E. coli
CFT073 Strr (Table 1) in the following manner. The donor and recipient strains were grown overnight,
with shaking, in LB broth at 30°C. Aliquots of 100 l of each culture were mixed together in 5 ml of
10 mM MgSO4 and ﬁltered through a 0.45-m-pore-size membrane ﬁlter (EMD Millipore). The ﬁlter was
placed on the surface of an LB agar plate and incubated for 5 h at 37°C. Following incubation, the
bacteria on the ﬁlter were suspended in 5 ml of 10 mM MgSO4, 100-l aliquots of the suspension were
plated on LB agar containing streptomycin sulfate (100 g/ml) and kanamycin sulfate (80 g/ml), and the
plates were incubated for 18 h at 37°C. Individual mini-Tn5 Km mutant colonies were transferred on
toothpicks to 2 LB agar plates, one lacking and one containing ampicillin sodium salt (100 g/ml;
Sigma-Aldrich, Inc.). Colonies that were ampicillin sensitive, signifying loss of the pUT suicide plasmid,
were transferred on toothpicks to sterile 16-mm-diameter culture tubes containing 250 l of 0.2%
glucose M9 minimal medium. The culture tubes were incubated overnight at 37°C with shaking, and then
5 ml of M9 minimal medium lacking a carbon source was added to each tube and 3 l from each tube
was spotted on a 0.2% glucose M9 minimal medium agar plate. The spots were allowed to dry (with lids
slightly ajar), and the plates were incubated overnight at 37°C. Each spotted mini-Tn5 Km mutant that
grew was retested by seeding 105 CFU of an overnight 10-ml 0.4% glucose M9 minimal medium liquid
culture on a 0.2% glucose M9 minimal medium agar plate and incubating at 37°C for 24 h. The gene
inactivated in each of the mini-Tn5 Km mutants that grew as a lawn was determined by arbitrary PCR
(18), as described below. In addition, to be sure that the mini-Tn5 Km insertion was the cause of the
ability of the individual mutants to grow on glucose plates, the insertion in each mutant was transferred
into a fresh E. coli CFT073 Strr background by the method of Wanner and Datsenko (14). Each mutant
thus obtained was conﬁrmed for the ability to grow as a lawn on glucose plates and for the position of
the insertion within the E. coli CFT073 chromosome by both PCR and sequencing (Table 4 lists the
primers used). Five conﬁrmed mutants were isolated from approximately 2,000 mini-Tn5 Km mutants
tested.
Arbitrary PCR. Arbitrary PCR was performed as described previously (18). Genomic DNA was isolated
from E. coli CFT073 mini-Tn5 Km mutants using the Wizard genomic DNA puriﬁcation kit (Promega). The
ﬁrst round of PCR was performed in 25-l reaction mixture volumes containing 1 standard Taq reaction
buffer (New England Biolabs, Inc.), 2 mM deoxynucleoside triphosphates, 100 M arbitrary primer 1
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(5= GGCCACGCGTCGACTAGTACNNNNNNNNNNNNGATAT 3=), 10 M Tn5-speciﬁc primer (5= TCTG-
GATTTCGATCACGGCACGT 3=), Taq DNA polymerase (2 units; New England Biolabs, Inc.), and DNA from
1.25 l of an overnight LB broth culture. The ﬁrst-round cycling conditions were as follows: (i) 4 min at
95°C, (ii) 6 cycles of 30 s at 95°C, 30 s at 30°C, and 1.5 min at 72°C 1.5, (iii) 30 cycles of 30 s at 95°C, 30 s
at 45°C, and 2 min at 72°C, and (iv) 4 min at 72°C. The second round of PCR used standard conditions
and cycling as follows: (i) 4 min at 95°C, (ii) 35 cycles of 30 s at 95°C, 30 s at 55°C, and 2 min at 72°C, and
(iii) 4 min at 72°C, with 0.5 l of the ﬁrst-round PCR product as the template, 10 M arbitrary primer 2
(5= GGCCACGCGTCGACTAGTAC 3=), and 10 M of a second Tn5-speciﬁc primer (5= TTACCGAGAGCTTG-
GTACCCAGTC 3=). The second-round-PCR products were column puriﬁed with a QIAquick PCR puriﬁca-
tion kit (Qiagen) and sequenced using a third Tn5-speciﬁc primer (5= GTACCCAGTCTGTGTGAGCAGG 3=).
DNA sequencing was done at the URI Genomics and Sequencing Center, University of Rhode Island,
Kingston, RI, using an Applied Biosystems 3130xl genetic analyzer (Applied Biosystems, Foster City, CA).
A BigDye Terminator cycle sequencing kit (version 3.1; Applied Biosystems) was used for the sequencing
reactions. The sequences were compared with the GenBank DNA sequence database using the BLASTX
program.
Identiﬁcation and quantitation of amino acids in E. coli MG1655 and E. coli CFT073 50-fold-
concentrated culture supernatants. E. coliMG1655 was grown overnight in ﬁve 10-ml cultures in liquid
0.4% glucose M9 minimal medium with shaking at 37°C in 125-ml tissue culture bottles. The cultures
were pooled, and cells were centrifuged for 10 min at 8,000 g and resuspended in 1 ml of 0.2% glucose
M9 minimal medium. The 50-fold-concentrated cultures were incubated standing overnight at 37°C in
1.5-ml centrifuge tubes (Celltreat Scientiﬁc Products). Cells were then centrifuged at 16,000 g for 3 min,
and the supernatant was removed and ﬁltered free of bacteria using a 0.22-m mixed cellulose ester
(MCE) syringe ﬁlter (Fisherbrand). E. coli CFT073 concentrated culture supernatants were prepared
identically.
The amino acids in 50-fold-concentrated culture supernatants were identiﬁed and quantiﬁed using
a slightly modiﬁed version of a method described by Yuan et al. (19). The method uses the AccQ-Tag
amino acid analysis method (Waters Corp., Milford, MA) with a pre-column derivatization kit (http://
www.waters.com/webassets/cms/support/docs/wat0052881.pdf). Acid hydrolysis was not included in
the derivatization step to ensure that only free amino acids were quantiﬁed. The method uses high-
performance liquid chromatography (HPLC) to separate the derivatized amino acids and a ﬂuorescence
detector to identify and quantify them. The chromatographic method using AccQ tag eluent A (solvent
A) and 60% acetonitrile in water (solvent B) was as follows: consecutive linear gradients of 0 to 2% B over
0.5 min; 2 to 7% B over 14.5 min; 7 to 10% B over 4 min; 10 to 20% B over 11 min; 20 to 36% B over
10 min; and 36 to 100% B over 5 min. The method totals 45 min of gradients and an additional 11-min
washout phase. The ﬂow rate was constant at 0.7 ml/min using a Waters AccQ Tag column (150 by
3.9 mm) held at a 40°C and injecting 5-l aliquots. The ﬂuorescence detector was set to an excitation
wavelength of 250 nm and emission wavelength of 395 nm, according to the manufacturer’s instructions.
Amino acids were identiﬁed by comparison to derivatized amino acid reference standards in the
following order: tryptophan, 6-aminoquinoline (AMQ; a product of the derivatization process), aspartic
acid, serine, glutamic acid, glycine, histidine, ammonium ion, arginine, threonine, alanine, proline,
cysteine, tyrosine, valine, methionine, lysine, isoleucine, leucine, phenylalanine. A calibration curve was
generated to quantify each amino acid present.
Persister assay. Overnight cultures in liquid 0.4% glucose M9 minimal medium were grown as
described in “Lawn assay for quiescence” above. Cultures were then diluted 20-fold into 10 ml of fresh
0.2% glucose M9 minimal medium (A600 of 0.1, ~108 CFU/ml) in both the presence and absence of
ampicillin sodium salt (100 g/ml; Sigma-Aldrich, Inc.). The cultures were incubated with shaking at 37°C,
and viable counts on LB agar plates were determined at 2, 4, 6, and 24 h. To determine whether cells
surviving at 24 h in the presence of ampicillin were persister cells or ampicillin-resistant mutants, 5-ml
amounts were washed free of ampicillin by centrifuging at 16,000  g for 3 min, washing cell pellets
twice in 5 ml of fresh 0.2% glucose M9 minimal medium, and resuspending cells in 5 ml of LB broth. Each
5-ml culture was then grown for 2.25 h at 37°C with shaking in a 125-ml tissue culture bottle, at which
time a sample was taken for viable count. Ampicillin sodium salt (100 g/ml) was then added to each
culture, and 4 h later, a sample was again taken for viable count assay on LB agar plates. Plates were
incubated at 37°C for 18 h prior to counting.
Photography. Images of agar plates were made using a Bio-Rad Molecular imager Gel Doc XR
system with Image Lab Software.
Statistics. The mean results and standard deviations of the data are presented in Table 4. The data
in Fig. 4, 5, 7, 8, and 9 were compared by a two-tailed Student’s t test. P values of0.05 were interpreted
as indicating a signiﬁcant difference.
TABLE 4 PCR primer sequences for amplifying mutant genes containing mini-Tn5 Km
insertions
Gene Primer 1 (5=¡3=) Primer 2 (5=¡3=)
gdhA GATGGTCGAGTGGCAGATTAC CAGAGGCTACTCAATGGCTTAC
gnd GTTGGTTAAATCAGATTAATCCAGCC CAACAGATCGGCGTAGTCG
pykF CTGTAGCAATTGAGCGATGATG ATCAGGGCGCTTCGATATAC
sdhA CCGTTCCCATACCGTTTCTG TTTCACCGGATCAACGTGAG
zwf CCGGTAAAATAACCATAAAGGATAAGC GAGAATGACATGGCGGTAAC
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